SCHEMBL25935368

SCHEMBL25935368

Cc1ncc(B2OC(C)(C)C(C)(C)O2)c(OCc2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.43
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPK1 P28482 2/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
ATP4A P20648 1/20 0.35
ATP4B P51164 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PDE5A O76074 1/20 0.35
STAT3 P40763 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DAPK1 P53355 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24978007 0.87 DGAT1 (0.47) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL2487182 0.86 PIN1 (0.49) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL25482311 0.83 DGAT1 (0.46) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL19585801 0.81 DGAT1 (0.46) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL29532520 0.81 DGAT1 (0.46) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL1360465 0.77 DGAT1 (0.47) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL18301360 0.77 DGAT1 (0.47) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL2673894 0.76 L3MBTL1 (0.42) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1
SCHEMBL26447438 0.75 DGAT1 (0.46) DGAT1L3MBTL1ALDH1A1GAAMAPK1
SCHEMBL25447041 0.75 DGAT1 (0.43) DGAT1L3MBTL1NR1H2NR1H3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 DGAT1 2465/4885L3MBTL1 964/4885NR1H2 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.